Leave your feedback Share Copy URL https://gographicsoutput.com/video/ONaMDmsODE2.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter 2027 CMS Medicare Final Rule: What Agents Need to Know [RpeXoEOdYV0] Health Updated on August 07, 2026 EDT — Published on August 07, 2026 EDT In this episode of The Broker Link Podcast, Mike Smith and Josh Slattery break down the key updates from the 2027 CMS Medicare Final Rule and what it means for agent partners. One of the biggest headlines is the rate increase for Medicare Advantage plans, rising from 0.9% to 2.48%, which injects approximately $13 billion into the system. While this funding boost is significant, it will likely influence product design, including potential reductions in certain non-essential supplemental benefits. The discussion also highlights the codification of the Inflation Reduction Act provision that caps out-of-pocket prescription drug costs at $2,100, providing greater financial protection for beneficiaries. From a compliance standpoint, several important changes are addressed. The removal of the 48-hour waiting period for Scope of Appointment and the reduction of call recording retention requirements from 10 years to 6 years are expected to streamline agent workflows while maintaining regulatory standards. The episode also explores the evolving focus of Star Ratings, with a shift toward clinical outcomes and away from administrative measures — signaling a broader move toward quality of care and patient results. The Brokerage Inc. will continue to keep you informed about CMS changes for 2027. Visit our website, www.thebrokerageinc.com to learn more. Remember to like, share, and subscribe to our show! New episodes are available every Tuesday. Join our Community! LinkedIn: Facebook: Instagram: YouTube: Website: pDv7PIgaqKb uNpiYgc0aq3 hJqUmWS8Zps zB7P7HnffKT O4BVAqlpDjF 4GY48EvVpW6
In this episode of The Broker Link Podcast, Mike Smith and Josh Slattery break down the key updates from the 2027 CMS Medicare Final Rule and what it means for agent partners. One of the biggest headlines is the rate increase for Medicare Advantage plans, rising from 0.9% to 2.48%, which injects approximately $13 billion into the system. While this funding boost is significant, it will likely influence product design, including potential reductions in certain non-essential supplemental benefits. The discussion also highlights the codification of the Inflation Reduction Act provision that caps out-of-pocket prescription drug costs at $2,100, providing greater financial protection for beneficiaries. From a compliance standpoint, several important changes are addressed. The removal of the 48-hour waiting period for Scope of Appointment and the reduction of call recording retention requirements from 10 years to 6 years are expected to streamline agent workflows while maintaining regulatory standards. The episode also explores the evolving focus of Star Ratings, with a shift toward clinical outcomes and away from administrative measures — signaling a broader move toward quality of care and patient results. The Brokerage Inc. will continue to keep you informed about CMS changes for 2027. Visit our website, www.thebrokerageinc.com to learn more. Remember to like, share, and subscribe to our show! New episodes are available every Tuesday. Join our Community! LinkedIn: Facebook: Instagram: YouTube: Website: pDv7PIgaqKb uNpiYgc0aq3 hJqUmWS8Zps zB7P7HnffKT O4BVAqlpDjF 4GY48EvVpW6